Research Article
Placental Growth Factor, Soluble fms-Like Tyrosine Kinase 1, Soluble Endoglin, IL-6, and IL-16 as Biomarkers in Preeclampsia
Table 3
AUC,
value, odds ratio, and prevalence of sEng, PlGF, sFlt1, IL-6, and IL-16.
| | Prevalence | Gestational age | AUC | value | <34 wk (%) | ≥34 wk (%) |
| sEng (ng/mL) | 0.439 | 56 | 44 | 0.610 | 0.106 | PlGF (pg/mL) | 0.446 | 55 | 45 | 0.684 | 0.005 | IL-16 (pg/mL) | 0.439 | 56 | 44 | 0.650 | 0.030 | IL-6 (pg/mL) | 0.439 | 56 | 44 | 0.568 | NS | sFlt-1 (pg/mL) | 0.439 | 56 | 44 | 0.511 | NS | sFlt-1/PlGF | 0.386 | 61 | 39 | 0.349 | 0.015 |
|
|
Early onset PE. Late onset PE.
|